Literature DB >> 16164619

Targets to retard the progression of diabetic nephropathy.

Mark E Cooper1, Karin Jandeleit-Dahm, Merlin C Thomas.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16164619     DOI： 10.1111/j.1523-1755.2005.00555.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

Review 1.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

2.  Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

Authors:  T M E Davis; R Ting; J D Best; M W Donoghoe; P L Drury; D R Sullivan; A J Jenkins; R L O'Connell; M J Whiting; P P Glasziou; R J Simes; Y A Kesäniemi; V J Gebski; R S Scott; A C Keech
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

3.  Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.

Authors:  Yves Gorin; Rita C Cavaglieri; Khaled Khazim; Doug-Yoon Lee; Francesca Bruno; Sachin Thakur; Paolo Fanti; Cédric Szyndralewiez; Jeffrey L Barnes; Karen Block; Hanna E Abboud
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-04

4.  The prevalence of albuminuria among diabetic patients in a primary care setting in Singapore.

Authors:  Eng Sing Lee; Wern Ee Tang
Journal:  Singapore Med J       Date:  2015-12       Impact factor: 1.858

5.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

Authors:  Jinhua Li; Xinli Qu; John F Bertram
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

6.  Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study.

Authors:  Ru-Dee Ting; Anthony C Keech; Paul L Drury; Mark W Donoghoe; John Hedley; Alicia J Jenkins; Timothy M E Davis; Seppo Lehto; David Celermajer; R John Simes; Kushwin Rajamani; Kim Stanton
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

7.  Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia.

Authors:  Mohammad Jafari; Farahnaz Dadras; Hamid Reza Ghadimipour; Mohamad Ali Seif Rabiei; Farhad Khoshjou
Journal:  J Nephropathol       Date:  2016-08-03

Review 8.  Mitochondrial Pathophysiology on Chronic Kidney Disease.

Authors:  Patrícia C Braga; Marco G Alves; Anabela S Rodrigues; Pedro F Oliveira
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

9.  Alteration of renal respiratory Complex-III during experimental type-1 diabetes.

Authors:  Shankar Munusamy; Hamida Saba; Tanecia Mitchell; Judit K Megyesi; Robert W Brock; Lee Ann Macmillan-Crow
Journal:  BMC Endocr Disord       Date:  2009-01-23       Impact factor: 2.763
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.